- ICH GCP
- 미국 임상 시험 레지스트리
- Search trials
Eli Lilly and Company가 후원하는 임상 시험
총 2632 건
-
Eli Lilly and CompanyGynecologic Oncology Group완전한신생물 | 비뇨생식기 신생물 | 부위별 신생물 | 자궁 신생물 | 생식기 신생물, 여성 | 자궁내막 신생물 | 자궁내막암 | 자궁내막암 | 자궁내막암 | 자궁내막암 | 신생물, 자궁내막미국
-
Kraepelin Psiquiatria ClinicaEli Lilly and Company완전한
-
Dana-Farber Cancer InstituteEli Lilly and Company모병
-
Jonsson Comprehensive Cancer CenterEli Lilly and Company모병
-
Dana-Farber Cancer InstituteEli Lilly and Company모병
-
Eli Lilly and CompanyMerck Sharp & Dohme LLC모집하지 않고 적극적으로
-
Dana-Farber Cancer InstituteEli Lilly and Company모집하지 않고 적극적으로
-
Dana-Farber Cancer InstituteEli Lilly and Company모집하지 않고 적극적으로
-
Eli Lilly and CompanyAlzheimer's Therapeutic Research Institute완전한
-
University of California, IrvineEli Lilly and Company종료됨
-
Jonsson Comprehensive Cancer CenterEli Lilly and Company종료됨임상 3기 HPV 매개(p16 양성) 구강인두 암종 AJCC v8 | 임상 IV기 HPV 매개(p16 양성) 구강인두 암종 AJCC v8 | 병리학적 III기 HPV 매개(p16 양성) 구강인두 암종 AJCC v8 | 병리학적 병기 IV HPV 매개(p16 양성) 구강인두 암종 AJCC v8 | KRAS 단백질 변이체미국
-
Charite University, Berlin, GermanyEli Lilly and Company빼는
-
Dana-Farber Cancer InstituteEli Lilly and Company모집하지 않고 적극적으로
-
Sansum Diabetes Research InstituteEli Lilly and Company완전한
-
University of Maryland, BaltimoreEli Lilly and Company완전한
-
University Hospital, Gentofte, CopenhagenEli Lilly and Company초대로 등록
-
Eli Lilly and CompanyMerck Sharp & Dohme LLC완전한
-
Jonsson Comprehensive Cancer CenterEli Lilly and Company완전한
-
Eli Lilly and CompanyMerck Sharp & Dohme LLC빼는
-
Dana-Farber Cancer InstituteEli Lilly and Company빼는발덴스트롬 마크로글로불린혈증 | 맨틀 세포 림프종 | 변연부 림프종 | 만성림프구성백혈병
-
Dana-Farber Cancer InstituteEli Lilly and Company종료됨
-
Sansum Diabetes Research InstituteEli Lilly and Company완전한
-
Rambam Health Care CampusEli Lilly and Company완전한
-
Eli Lilly and CompanyNippon Shinyaku Co., Ltd.완전한
-
University Hospital, Gentofte, CopenhagenEli Lilly and Company완전한
-
Stanford UniversityEli Lilly and Company; Genentech, Inc.완전한
-
Sun Yat-sen UniversityEli Lilly and Company알려지지 않은결절외 NK/T 세포 림프종, 비강형중국
-
AstraZenecaEli Lilly and Company; i3 Drug Safety완전한Type 2 Diabetes (Treated With Exenatide or Other Oral Antidiabetic Therapies) | Healthy Subjects (Treated With no Diabetes Therapies)미국
-
Rehabilitation Hospital of IndianaEli Lilly and Company종료됨
-
M.D. Anderson Cancer CenterEli Lilly and Company종료됨
-
Sun Yat-sen UniversityEli Lilly and Company완전한
-
Hospital Authority, Hong KongEli Lilly and Company알려지지 않은
-
University Hospital MuensterEli Lilly and Company; Bayer종료됨
-
National University Hospital, SingaporeEli Lilly and Company완전한
-
Charles University, Czech RepublicEli Lilly and Company완전한
-
CONKO-StudiengruppeEli Lilly and Company; medac GmbH완전한
-
Central Hospital, Nancy, FranceEli Lilly and Company아직 모집하지 않음
-
University Health Network, TorontoEli Lilly and Company모집하지 않고 적극적으로
-
Eli Lilly and CompanyMerck Sharp & Dohme LLC완전한
-
Jonsson Comprehensive Cancer CenterEli Lilly and Company완전한
-
Duke UniversityEli Lilly and Company; Boehringer Ingelheim모집하지 않고 적극적으로
-
Translational Genomics Research InstituteEli Lilly and Company빼는
-
SCRI Development Innovations, LLCEli Lilly and Company완전한
-
Sansum Diabetes Research InstituteEli Lilly and Company완전한
-
Eli Lilly and CompanySarah Cannon Development Innovations완전한
-
National Taiwan University HospitalEli Lilly and Company완전한과잉 행동을 동반한 주의력 결핍 장애대만